| Pharmaceutical active ingredients: |
| Betamethasone Valero-AcetateClioquinol |
| Available forms, composition and doses of Viobeta: |
| N / A |
| Viobeta medical category: |
| Human |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| P01AA52 - Clioquinol, combinations |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| IDI Farmaceutici |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Betnovate-S | Betamethasone Valerate; Salicylic Acid | GlaxoSmithKline |
| Betosalic | Betamethasone Valerate; Salicylic Acid | T.O. Chemicals 1979; Joyson |
| Soderm Plus | Betamethasone Valerate; Salicylic Acid | Dermapharm |
| Beta 21 | Betamethasone Valero-Acetate | IDI Farmaceutici |
| P 10 | Betamethasone Valero-Acetate | Pulitzer Italiana |
| Dermatar | Betamethasone Valero-Acetate; Ichthammol; Salicylic Acid | IDI Farmaceutici |
| Apsor | Betamethasone Valero-Acetate; Salicylic Acid; Tretinoin | IDI Farmaceutici |
| Psorinase | Betamethasone Valero-Acetate; Salicylic Acid; Tretinoin | IDI Farmaceutici |
| Celestan | Betamethasone; Betamethasone Acetate; Betamethasone Sodium Phosphate | Schering-Plough; Aesca; Essex; Teuto-Brasileiro Laboratorio |
| Celeston | Betamethasone; Betamethasone Acetate; Betamethasone Sodium Phosphate; Betamethasone Valerate | Schering-Plough; Bayer Schering Pharma; Essex |